U.S. Pharmacist



More Is Not Better When Taking NSAIDs



US Pharm. 2008;33(3):11.

When it comes to treating inflammatory diseases such as arthritis, taking more than one nonsteroidal anti-inflammatory drug (NSAID) could lead to complications beyond the common gastrointestinal side effects associated with some NSAID products. The uncontrolled availability of OTC NSAIDs has led patients to mix products thinking that more is better. A study led by Stacey H. Kovac of Durham VA Medical Center and Duke University found that taking two NSAIDs (prescription, OTC, or both) was associated with lower scores on a test that evaluates a patient's health status.

The study uncovered that many patients failed to tell their physician that they were taking more than one NSAID. Another factor leading to the dual intake of NSAIDs could be the lack of clinical pain management in the first place.

To comment on this article, contact editor@uspharmacist.com


U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

Copyright © 2000 - 2016 Jobson Medical Information LLC unless otherwise noted.
All rights reserved. Reproduction in whole or in part without permission is prohibited.